Your browser doesn't support javascript.
loading
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.
Marín-Jiménez, Juan A; Oliva, Marc; Peinado Martín, Paloma; Cabezas-Camarero, Santiago; Plana Serrahima, Maria; Vázquez Masedo, Gonzalo; Lozano Borbalas, Alicia; Cabrera Martín, María N; Esteve, Anna; Iglesias Moreno, María C; Vilajosana Altamis, Esther; Arribas Hortigüela, Lorena; Taberna Sanz, Miren; Pérez-Segura, Pedro; Mesía, Ricard.
Afiliação
  • Marín-Jiménez JA; Head and Neck Cancer Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Oliva M; Head and Neck Cancer Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Peinado Martín P; Oncobell Program - Bellvitge Biomedical Research Institute (Institut d'Investigació Biomèdica de Bellvitge), Barcelona, Spain.
  • Cabezas-Camarero S; Head and Neck Cancer Unit, Department of Medical Oncology, Hospital Universitario Clínico San Carlos - Instituto de Investigación Sanitaria Hospital Clínica San Carlos, Madrid, Spain.
  • Plana Serrahima M; Head and Neck Cancer Unit, Department of Medical Oncology, Hospital Universitario Clínico San Carlos - Instituto de Investigación Sanitaria Hospital Clínica San Carlos, Madrid, Spain.
  • Vázquez Masedo G; Head and Neck Cancer Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Lozano Borbalas A; Department of Radiation Oncology, Hospital Universitario Clínico San Carlos - Instituto de Investigación Sanitaria Hospital Clínica San Carlos (IdISCC), Madrid, Spain.
  • Cabrera Martín MN; Department of Radiation Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Esteve A; Department of Nuclear Medicine, Hospital Universitario Clínico San Carlos - IdISCC, Madrid, Spain.
  • Iglesias Moreno MC; Department of Medical Oncology, Catalan Institute of Oncology (ICO-Badalona), B-ARGO group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Barcelona, Spain.
  • Vilajosana Altamis E; Oncology Data Analytics Program, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat) - Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
  • Arribas Hortigüela L; Otolaryngology - Head and Neck Surgery Department, Hospital Universitario Clínico San Carlos e- IdISCC, Madrid, Spain.
  • Taberna Sanz M; Head and Neck Cancer Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Pérez-Segura P; Clinical Nutrition Unit, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
  • Mesía R; Head and Neck Cancer Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO - L'Hospitalet de Llobregat), Barcelona, Spain.
Front Oncol ; 12: 953020, 2022.
Article em En | MEDLINE | ID: mdl-35936723
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article